Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 2/2008

01-04-2008 | Original Article

A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum

Authors: Kentaro Yamazaki, Shuichi Hironaka, Narikazu Boku, Hirofumi Yasui, Akira Fukutomi, Takayuki Yoshino, Yusuke Onozawa, Noriaki Hasuike, Tetsuya Inui, Yuichiro Yamaguchi, Hiroyuki Ono

Published in: International Journal of Clinical Oncology | Issue 2/2008

Login to get access
Metadata
Title
A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum
Authors
Kentaro Yamazaki
Shuichi Hironaka
Narikazu Boku
Hirofumi Yasui
Akira Fukutomi
Takayuki Yoshino
Yusuke Onozawa
Noriaki Hasuike
Tetsuya Inui
Yuichiro Yamaguchi
Hiroyuki Ono
Publication date
01-04-2008
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2008
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-007-0738-y

Other articles of this Issue 2/2008

International Journal of Clinical Oncology 2/2008 Go to the issue

Original Article

Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer

Case Report

Small cell carcinoma of the prostate treated with amrubicin

Case Report

Efficacy of Nyoshinsan/TJ-67, a traditional herbal medicine, for menopausal symtoms following surgery and adjuvant chemotherapy for premenopausal breast cancer

Review Article

A history of the cancer registration system in Japan

Case Report

Cavernous hemangioma mimicking a cystic renal cell carcinoma

Case Report

Small cell carcinoma of the ovary: clinical and biological study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits